The company's biotechnology platform uses commonalities across the ATPase target class to develop drugs from the previously intractable class of enzymes. By combining structural biology and small-molecule drug discovery, MOMA Therapeutics is able to unlock the untapped potential of molecular machines. The company is unapologetically scientific and believes in removing bureaucracy to achieve success. MOMA Therapeutics is composed of drug discovery professionals, industry specialists, and scientific experts who work together to deliver the next generation of precision medicines.